Literature DB >> 10761162

Pharmacokinetics of ketoprofen syrup in small children.

H Kokki1, A Le Liboux, A Jekunen, G Montay, M Heikkinen.   

Abstract

Ketoprofen is a nonsteroidal anti-inflammatory drug with analgesic, anti-inflammatory, and antipyretic properties. Its pharmacokinetics has not been determined in small children. The objective here was to determine the pharmacokinetics of ketoprofen syrup, 0.5 mg/kg, in two groups of 10 children. Group 1 was from ages 6 months up to 2 years (7/10 younger than 1 year), and Group 2 was from ages 2 to 7 years. Venous blood samples were collected before drug administration and 0.5, 1, 2, 4, 6, 8, and 12 hours after. A validated HPLC method was used to determine plasma levels of ketoprofen. The lower limit of quantification was 0.02 microgram/ml of plasma. Ketoprofen syrup was absorbed rapidly, the plasma level reaching its maximum at 0.5 hours, with C0.5 hours = 3 micrograms/ml. The pharmacokinetics was similar between the two groups of children. The elimination half-life, 2.0 hours in Group 1 or 1.9 hours in Group 2, was similar to that reported in adults.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10761162     DOI: 10.1177/00912700022009053

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  11 in total

Review 1.  Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol.

Authors:  C Litalien; E Jacqz-Aigrain
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  Comparison of acetaminophen and ketoprofen in febrile children: a single dose randomized clinical trial.

Authors:  Saliha Senel; Nilgun Erkek; Can Demir Karacan
Journal:  Indian J Pediatr       Date:  2011-06-25       Impact factor: 1.967

3.  Ketoprofen versus paracetamol (acetaminophen) or ibuprofen in the management of fever: results of two randomized, double-blind, double-dummy, parallel-group, repeated-dose, multicentre, phase III studies in children.

Authors:  Hannu Kokki; Merja Kokki
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

4.  Dose-finding studies of ketoprofen in the management of fever in children: report on two randomized, single-blind, comparator-controlled, single-dose, multicentre, phase II studies.

Authors:  Hannu Kokki; Merja Kokki
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

Review 5.  Ketoprofen pharmacokinetics, efficacy, and tolerability in pediatric patients.

Authors:  Hannu Kokki
Journal:  Paediatr Drugs       Date:  2010-10-01       Impact factor: 3.022

6.  Pharmacokinetics of intravenous and rectal ketoprofen in young children.

Authors:  Hannu Kokki; Marko Karvinen; Pekka Suhonen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

7.  Antipyretic effect of ketoprofen.

Authors:  S Celebi; M Hacimustafaoglu; D Aygun; E S Arisoy; Y Karali; S Akgoz; A N Citak Kurt; M Seringec
Journal:  Indian J Pediatr       Date:  2009-01-05       Impact factor: 1.967

Review 8.  Nonsteroidal anti-inflammatory drugs for postoperative pain: a focus on children.

Authors:  Hannu Kokki
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

9.  Pharmacokinetics of oxycodone after intravenous, buccal, intramuscular and gastric administration in children.

Authors:  Hannu Kokki; Ilpo Rasanen; Matti Reinikainen; Pekka Suhonen; Kari Vanamo; Ilkka Ojanperä
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 10.  Postoperative pain control in children: a guide to drug choice.

Authors:  Eva Kokinsky; Eva Thornberg
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.